Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.54 USD | -0.68% | -3.39% | +12.09% |
Apr. 11 | Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes | MT |
Feb. 26 | Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating | MT |
Financials (USD)
Sales 2024 * | 584M | Sales 2025 * | 596M | Capitalization | 1.14B |
---|---|---|---|---|---|
Net income 2024 * | 116M | Net income 2025 * | 144M | EV / Sales 2024 * | 2.24 x |
Net Debt 2024 * | 167M | Net cash position 2025 * | 42.16M | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
11.8
x | P/E ratio 2025 * |
9.47
x | Employees | 197 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.62% |
Latest transcript on Collegium Pharmaceutical, Inc.
1 day | -1.92% | ||
1 week | -4.45% | ||
Current month | -10.43% | ||
1 month | -11.64% | ||
3 months | +5.78% | ||
6 months | +59.86% | ||
Current year | +12.96% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 01-12-31 | |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 17-05-30 |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 21-05-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 14-12-31 |
Gino Santini
BRD | Director/Board Member | 66 | 12-07-23 |
John Freund
BRD | Director/Board Member | 70 | 14-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 29 M€ | -6.85% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 34.5 | -0.78% | 119 204 |
24-04-18 | 34.77 | -1.92% | 203,939 |
24-04-17 | 35.45 | +0.14% | 256,530 |
24-04-16 | 35.4 | +0.74% | 323,773 |
24-04-15 | 35.14 | -1.60% | 366,303 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.96% | 1.14B | |
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- COLL Stock